Castle Creek Pharmaceuticals is a privately held biopharmaceutical company developing innovative therapies for patients with rare and serious genetic diseases. The company, with offices currently in Basking Ridge, New Jersey and Chicago, Illinois, is dedicated to developing and bringing novel therapies to those living with epidermolysis bullosa
